The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Danish Medical Journal

• Publication date

  2012-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 22951205
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Dose and Combination of Antihypertensives on Interindividual Blood Pressure Variability: A Systematic Review

  2011cited by this paper
• Differences in presentation of symptoms between women and men with intermittent claudication

  2011cited by this paper
• Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?

  2011cited by this paper
• The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients

  2011cited by this paper
• High Risk of Peripheral Arterial Disease in the United Kingdom: 2-Year Results of a Prospective Registry

  2011cited by this paper
• Secondary Pharmacotherapeutic Prevention among German Primary Care Patients with Peripheral Arterial Disease

  2011cited by this paper
• Secondary medical prevention in patients with peripheral arterial disease - prescriptions of vascular surgeons and medical doctors (angiologists) in a multidisciplinary vascular centre.

  2010cited by this paper
• A systematic review of implementation of established recommended secondary prevention measures in patients with PAOD.

  2010cited by this paper
• Medical Prophylaxis following Hospitalization for Ischemic Stroke: Age- and Sex-Related Differences and Relation to Mortality

  2010cited by this paper
• EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries

  2010cited by this paper
• Relation of pre-event use of inhibitors of the renin-angiotensin system with myocardial infarct size in patients presenting with a first ST-segment elevation myocardial infarction.

  2010cited by this paper
• Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

  2009cited by this paper
• A propensity-matched study of the association of peripheral arterial disease with cardiovascular outcomes in community-dwelling older adults.

  2009cited by this paper
• Beta blockers for peripheral arterial disease.

  2009cited by this paper
• Treatment of hypertension in peripheral arterial disease.

  2009cited by this paper
• Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease

  2009cited by this paper
• Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis.

  2008cited by this paper
• Use of Secondary Prevention Drug Therapy in Patients With Acute Coronary Syndrome After Hospital Discharge

  2008cited by this paper
• Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.

  2008cited by this paper
• Clinical outcome in patients with peripheral artery disease. Results from a prospective registry (FRENA).

  2008cited by this paper
• Management of hypertension in peripheral arterial disease.

  2008cited by this paper
• Reduced arterial stiffness may contribute to angiotensin-converting enzyme inhibitor induced improvements in walking time in peripheral arterial disease patients

  2008cited by this paper
• Peripheral artery disease: potential role of ACE-inhibitor therapy

  2008cited by this paper
• Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease.

  2008cited by this paper
• Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement.

  2007cited by this paper
• Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.

  2007cited by this paper
• Peripheral Arterial Disease Study (PERART): Prevalence and predictive values of asymptomatic peripheral arterial occlusive disease related to cardiovascular morbidity and mortality

  2007cited by this paper
• The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials

  2007cited by this paper
• A prognostic risk index for long-term mortality in patients with peripheral arterial disease.

  2007cited by this paper
• Arterial vascular disease in women.

  2007cited by this paper
• The Danish Civil Registration System. A cohort of eight million persons.

  2006cited by this paper
• Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease.

  2006cited by this paper
• Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

  2006cited by this paper
• Brief Communication: Ramipril Markedly Improves Walking Ability in Patients with Peripheral Arterial Disease

  2006cited by this paper
• International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.

  2006cited by this paper
• Statin treatment and adherence to national cholesterol guidelines after ischemic stroke

  2006cited by this paper
• ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography

  2006cited by this paper
• Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

  2005cited by this paper
• Clinical practice. Chronic stable angina.

  2005cited by this paper
• Sensitivity and Specificity of the Ankle–Brachial Index to Predict Future Cardiovascular Outcomes: A Systematic Review

  2005cited by this paper
• A modified poisson regression approach to prospective studies with binary data.

  2004cited by this paper
• High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study.

  2004cited by this paper
• Statin therapy improves cardiovascular outcome of patients with peripheral artery disease.

  2004cited by this paper
• Improved Prediction of Fatal Myocardial Infarction Using the Ankle Brachial Index in Addition to Conventional Risk Factors: The Edinburgh Artery Study

  2004cited by this paper
• Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999–2000

  2004cited by this paper
• Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease.

  2004cited by this paper
• Accuracy of clinical data in a population based vascular registry.

  2004cited by this paper
• Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction.

  2004cited by this paper
• Re: "Estimating the relative risk in cohort studies and clinical trials of common outcomes".

  2004cited by this paper
• Relationship of High and Low Ankle Brachial Index to All-Cause and Cardiovascular Disease Mortality: The Strong Heart Study

  2004cited by this paper
• Determination of Lipid Profiles and Use of Statins in Patients With Ischemic Stroke or Transient Ischemic Attack

  2003cited by this paper
• Platelet activation is increased in peripheral arterial disease.

  2003cited by this paper
• Cholesterol Reduction With Atorvastatin Improves Walking Distance in Patients With Peripheral Arterial Disease

  2003cited by this paper
• Intensive Blood Pressure Control Reduces the Risk of Cardiovascular Events in Patients With Peripheral Arterial Disease and Type 2 Diabetes

  2003cited by this paper
• The potential role of angiotensin-converting enzyme inhibition in peripheral arterial disease

  2003cited by this paper
• Sex Differences in Peripheral Arterial Disease: Leg Symptoms and Physical Functioning

  2003cited by this paper
• Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study.

  2002cited by this paper
• Missed Opportunities to Treat Atherosclerosis in Patients Undergoing Peripheral Vascular Interventions: Insights From the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2)

  2002cited by this paper
• Cardiovascular protection and blood pressure reduction: a meta-analysis.

  2001cited by this paper
• Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease.

  2001cited by this paper
• Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non-ST-elevation acute coronary syndromes.

  2001cited by this paper
• The lack of cardiovascular risk factor management in patients with critical limb ischaemia.

  2001cited by this paper
• When an Entire Country Is a Cohort

  2000cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• The Danish National Hospital Register. A valuable source of data for modern health sciences.

  1999cited by this paper
• Effects of beta-blockers on the concentration and oxidizability of plasma lipids.

  1998cited by this paper
• Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction.

  1998cited by this paper
• Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk.

  1998cited by this paper
• Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S).

  1998cited by this paper
• Estimating Causal Effects from Large Data Sets Using Propensity Scores

  1997cited by this paper
• Atherosclerotic Risk Factors Are Less Intensively Treated in Patients with Peripheral Arterial Disease Than in Patients with Coronary Artery Disease

  1997cited by this paper
• Intermittent claudication. A risk profile from The Framingham Heart Study.

  1997cited by this paper
• Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.

  1996cited by this paper
• Impact of cholesterol reduction on peripheral arterial disease in the Program on the Surgical Control of the Hyperlipidemias (POSCH).

  1996cited by this paper
• Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review.

  1996cited by this paper
• Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study.

  1995cited by this paper
• Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.

  1994cited by this paper
• Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations.

  1993cited by this paper
• Double-Blind Comparison of Captopril with Nifedipine in Hypertension Complicated by Intermittent Claudication

  1992cited by this paper
• Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

  1992cited by this paper
• Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study.

  1992cited by this paper
• Mortality over a period of 10 years in patients with peripheral arterial disease.

  1992cited by this paper
• Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population.

  1991cited by this paper
• Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials.

  1991cited by this paper
• The effect of enalapril on leg muscle blood flow in patients with claudication.

  1990cited by this paper
• Effect of Metoprolol on Diet‐Induced Atherosclerosis in Rabbits

  1988cited by this paper
• The effects of beta-adrenergic blocking agents on atherosclerosis and its complications.

  1987cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper
• Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.

  1981cited by this paper

• The effect of telemedicine on secondary prevention of atherosclerotic cardiovascular disease: A systematic review and meta-analysis

  2022cites this paper
• Aktuelle Aspekte der β-Blocker-Therapie zur Sekundärprävention und Kardioprotektion bei Gefäßpatienten

  2020cites this paper
• The value of WeChat application in chronic diseases management in China

  2020cites this paper
• Diagnosis of peripheral arterial disease based on distal limb pressures

  2014cites this paper
• Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: A randomized controlled trial. Journal of the American Medical Association 2013; 309: 453–460

  2013cites this paper